Literature DB >> 8003977

Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen.

C L Fisher1, J S Greengard, J H Griffin.   

Abstract

Three-dimensional structural analysis of physiologically important serine proteases is useful in identifying functional features relevant to the expression of their activities and specificities. The human serine protease anticoagulant protein C is currently the object of many genetic site-directed mutagenesis studies. Analyzing relationships between its structure and function and between naturally occurring mutations and their corresponding clinical phenotypes would be greatly assisted by a 3-dimensional structure of the enzyme. To this end, molecular models of the protease domain of protein C have been produced using computational techniques based on known crystal structures of homologous enzymes and on protein C functional information. The resultant models corresponding to different stages along the processing pathway of protein C were analyzed for structural and electrostatic differences arising during the process of protein C maturation and activation. The most satisfactory models included a calcium ion bound to residues homologous to those that ligate calcium in the trypsin structure. Inspection of the surface features of the models allowed identification of residues putatively involved in specific functional interactions. In particular, analysis of the electrostatic potential surface of the model delineated a positively charged region likely to represent a novel substrate recognition exosite. To assist with future mutational studies, binding of an octapeptide representing a protein C cleavage site of its substrate factor Va to the enzyme's active site region was modeled and analyzed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003977      PMCID: PMC2142866          DOI: 10.1002/pro.5560030407

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  47 in total

1.  Converting trypsin to chymotrypsin: the role of surface loops.

Authors:  L Hedstrom; L Szilagyi; W J Rutter
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

2.  Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate.

Authors:  M Dreyfus; J F Magny; F Bridey; H P Schwarz; C Planché; M Dehan; G Tchernia
Journal:  N Engl J Med       Date:  1991-11-28       Impact factor: 91.245

3.  Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.

Authors:  S P Bajaj; A K Sabharwal; J Gorka; J J Birktoft
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

4.  Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis.

Authors:  J F Collawn; M Stangel; L A Kuhn; V Esekogwu; S Q Jing; I S Trowbridge; J A Tainer
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

5.  The high affinity calcium-binding site involved in protein C activation is outside the first epidermal growth factor homology domain.

Authors:  A R Rezaie; N L Esmon; C T Esmon
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

6.  Post-translational processing events in the secretion pathway of human protein C, a complex vitamin K-dependent antithrombotic factor.

Authors:  D B McClure; J D Walls; B W Grinnell
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

7.  The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.

Authors:  H M Bakker; G Tans; T Janssen-Claessen; M C Thomassen; H C Hemker; J H Griffin; J Rosing
Journal:  Eur J Biochem       Date:  1992-08-15

8.  Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity.

Authors:  R M Mesters; R A Houghten; J H Griffin
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

9.  A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.

Authors:  R M Mesters; M J Heeb; J H Griffin
Journal:  Biochemistry       Date:  1993-11-30       Impact factor: 3.162

10.  Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.

Authors:  P Wildgoose; D Foster; J Schiødt; F C Wiberg; J J Birktoft; L C Petersen
Journal:  Biochemistry       Date:  1993-01-12       Impact factor: 3.162

View more
  7 in total

1.  Modeling zymogen protein C.

Authors:  L Perera; C Foley; T A Darden; D Stafford; T Mather; C T Esmon; L G Pedersen
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Screening the molecular surface of human anticoagulant protein C: a search for interaction sites.

Authors:  B O Villoutreix; D G Covell; A M Blom; A Wallqvist; U Friedrich; B Dahlbäck
Journal:  J Comput Aided Mol Des       Date:  2001-01       Impact factor: 3.686

3.  Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa.

Authors:  Masahiro Takeyama; Jennifer M Wintermute; Chandrashekhara Manithody; Alireza R Rezaie; Philip J Fay
Journal:  Biochemistry       Date:  2013-03-22       Impact factor: 3.162

4.  A structural model for the prostate disease marker, human prostate-specific antigen.

Authors:  B O Villoutreix; E D Getzoff; J H Griffin
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

5.  Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.

Authors:  B O Villoutreix; H Lilja; K Pettersson; T Lövgren; O Teleman
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

6.  Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.

Authors:  Liang Tang; Tao Guo; Rui Yang; Heng Mei; Huafang Wang; Xuan Lu; Jianming Yu; Qingyun Wang; Yu Hu
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

7.  Genetic association of PROC variants with pulmonary embolism in Northern Chinese Han population.

Authors:  Zengliang Wang; Tianhe Wang; Jianyong Chang; Hua Li; Chengdong Wang; Yongyong Li; Xuhe Lang; Shimei Jing; Guoqing Zhang; Yuting Wang
Journal:  Springerplus       Date:  2016-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.